Table 1 Characteristics of 241 patients at high risk of severe illness who had been prescribed oseltamivir
n of patients | (%) | |
|---|---|---|
High risk group description | ||
Age only | 53 | (22.0) |
Co-morbidity only | 101 | (41.9) |
Complicated course of illness only | 13 | (5.4) |
Age and co-morbidity | 49 | (20.3) |
Age and complicated course of illness | 2 | (0.8) |
Co-morbidity and complicated course | 15 | (6.2) |
Age, co-morbidity and complicated course | 8 | (3.3) |
Specific co-morbidity at risk for complications* | ||
Cardiac disease | 60 | (24.9) |
Respiratory disease | 106 | (44.0) |
Diabetes mellitus | 27 | (11.2) |
Chronic renal insufficiency | 5 | (2.1) |
Reduced resistance against infections | 24 | (10.0) |
Children using salicylates | 1 | (0.4) |
Third trimester of pregnancy | 3 | (1.2) |